Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders' MeetingGlobeNewsWire • 09/12/24
Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting DeadlineGlobeNewsWire • 07/09/24
Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 DeliveryGlobeNewsWire • 07/03/24
Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024GlobeNewsWire • 07/03/24
Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in ColombiaGlobeNewsWire • 06/17/24
Join Sharps Technology's Exclusive Live Investor Webinar and Q&A Session on June 18GlobeNewsWire • 06/14/24
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC FacilityGlobeNewsWire • 06/13/24
Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVAccesswire • 06/07/24
Sharps Technology's SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.GlobeNewsWire • 05/31/24
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.GlobeNewsWire • 05/30/24
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured SyringesGlobeNewsWire • 05/28/24
Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery SystemsGlobeNewsWire • 03/07/24
Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery SystemsGlobeNewsWire • 02/16/24
Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery SystemsGlobeNewsWire • 01/18/24
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.6 Million Registered Direct & Private Placement Priced at the Market Under Nasdaq Rules for Sharps Technology, Inc. (NASDAQ: STSS)Accesswire • 09/29/23
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private PlacementGlobeNewsWire • 09/29/23
Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TVAccesswire • 09/29/23
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron PharmaceuticalsGlobeNewsWire • 09/28/23
UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesGlobeNewsWire • 09/27/23
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesGlobeNewsWire • 09/27/23
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron PharmaceuticalsGlobeNewsWire • 09/26/23